宫清颗粒诱导药物流产人早孕绒毛、蜕膜细胞凋亡信号转导的研究
|
摘要
目的:从细胞凋亡信号转导的角度探讨化瘀、益气养血、清热中药宫清颗粒防治药物流产后异常子宫出血(简称药流后出血)的作用机制,并探讨流产药物抗早孕的机理,丰富中医学“产后多虚多瘀”理论的科学内涵,为临床防治本病提供实验室生物学依据。
方法:研究分现代中医文献研究和临床研究两大部分。现代中医文献研究中,以防治药流后出血的现代中医文献为研究对象,建立证治方药数据库,运用文献研究和统计学分析相结合的方法,从频数分析、因子分析、聚类分析角度对本病病因病机及证治规律进行统计分析。临床研究中,将180例患者随机分为宫清药流组、茜芷药流组及单纯药流组,并设人工流产组(简称人流组)患者60例,在观察临床疗效的同时,收集各组人早孕绒毛、蜕膜组织,透射电镜下观察绒毛及蜕膜组织细胞超微结构变化,并检测细胞凋亡率(AR)、凋亡信号转导相关指标凋亡因子Fas信使核糖核酸(FasmRNA)、Fas配体信使核糖核酸(FasLmRNA)、凋亡因子Fas、Fas配体(FasL)、蛋白激酶C(PKC)、细胞内钙离子浓度([Ca~(2+)]i)表达变化,分析指标间的相关性。
结果:现代中医文献研究显示,瘀、虚、热是药流后异常子宫出血的基本病因病机,活血化瘀、益气养血、清热是防治本病的基本原则,分析出了防治本病的高频药物及其配伍规律,为以活血化瘀、益气养血、清热法为组方原则的宫清颗粒防治本病提供了中医文献学依据。临床研究发现:宫清药流组孕囊排出时间较茜芷药流组及单纯药流组明显缩短,均有非常显著性差异(P＜0.01);宫清药流组子宫出血量明显减少,与茜芷药流组比较有显著性差异(P＜0.05),与单纯药流组比较有非常显著性差异(P＜0.01);宫清药流组子宫出血天数较单纯药流组明显缩短,有显著性差异(P＜0.05),与茜芷药流组比较无显著性差异(P＞0.05)。单纯药流组人早孕绒毛及蜕膜组织细胞超微结构观察发现细胞凋亡倾向,凋亡信号转导指标检测显示FasmRNA及FasLmRNA基因表达、Fas及FasL蛋白表达、[Ca~(2+)]i明显升高,PKC蛋白表达明显降低,与人流组比较有非常显著性差异(P＜0.01)。宫清颗粒的作用趋势与单纯药流药物相同,其作用效果较茜芷药流组与单纯药流组显著,超微结构观察发现宫清药流组绒毛及蜕膜组织细胞出现典型的凋亡形态学改变,凋亡信号转导指标检测显示,AR、FasmRNA基因及FasLmRNA基因表达、Fas蛋白及FasL蛋白表达、[Ca~(2+)]i较茜芷药流组、单纯药流组明显升高(P＜0.05,P＜0.01),PKC蛋白表达显著降低(P＜0.05,P＜0.01)。宫清药流组AR与FasmRNA基因、FasLmRNA基因、Fas蛋白、FasL蛋白表达及[Ca~(2+)]i呈正相关,与PKC蛋白表达呈负相关;FasmRNA基因表达与Fas蛋白表达呈正相关,FasLmRNA基因表达与FasL蛋白表达呈正相关,PKC蛋白表达与[Ca~(2+)]i呈负相关。
结论:药流药物通过影响Fas/FasL、PKC、Ca~(2+)介导的细胞凋亡信号转导途径,引起人早孕绒毛滋养细胞及蜕膜细胞凋亡,这可能是其抗早孕的机理之一。细胞凋亡不仅是药流的启动因素,同时凋亡障碍也是导致药流后异常子宫出血的原因之一。瘀、虚、热是药流后异常子宫出血的基本病因病机,以活血化瘀、益气养血、清热为组方原则的宫清颗粒从基因及蛋白水平调控Fas/FasL、PKC、Ca~(2+)介导的细胞凋亡信号转导途径,诱导药流人早孕绒毛滋养细胞及蜕膜细胞凋亡,促进绒毛与蜕膜组织的完全排出,进而达到防治药流后异常子宫出血的目的,其临床疗效及对细胞凋亡信号转导相关指标的调节作用明显优于茜芷药流组和单纯药流组。
Objective:To investigate the inducement mechanism of Gongqing granum concerning singnal transduction of human villi and decidua cell apoptosis,which is in the early pregnancy bleeding after drug abortion.In order to provide objective basis for preventing and treating the disease by Gongqing granum,furthermore,enrich the scientific connotation of the TCM theory that "there are more fragility and blood stasis after production".
Methods:In the modern TCM literature study,a database of recipes and herbs was founded with computer technology.Then analyzed the therapia rule from the point of frequency analysis,factor analysis and varable clustering analysis.In the clinical experimental investigation,the selected 240 patients were divided into 4 groups by random.They were group of Gongqing,group of Qianzhi,group of drug abortiona and group of induced abortion respectively.We observed the clinical curative effect of the 4 groups,at the same time,we collected the specimen of the 4 groups.Then we observed the ultrastructure of the specimen and detected the expression of apoptosis rate(AR) and correlative indexs of singnal transduction of cell apoptosis,such as FasmRNA,FasLmRNA, Fas,FasL,PKC and intracellular calcium concentration([Ca~(2+)])i,furthermore,we analyzed the relativity of the indexs.
Results:The TCM literature study showed that the main pathogen of bleeding after drug abortion were blood stasis,fragility and heat,which offered the philology evidence of Gongqing granula preventing and treating bleeding after drug abortion.The clinical experimental investigation showed that the clinical curative effect of Gongqing granum was obviously better than other groups(P＜0.01,P＜0.05).
The observation of ultrastructure indicated distinct change of apoptosis.Compared to the other 3 groups,the expression of AR,FasmRNA,FasLmRNA,Fas,FasL and([Ca~(2+)])i of Gongqing group were obviously higher than the other 3 groups(P＜0.01,P＜0.05),while the expression of PKC of Gongqing group was obviously lower than other 3 groups(P＜0.01, P＜0.05).
Results:Mifepristone can affect the singnal transduction of cell apoptosis caused by singnal transduction Fas/FasL,PKC and Ca~(2+).This may be one of the mechanisms of drug abortion.Blood stasis,fragility and heat are the main reasons of bleeding after drug abortion.Gongqing granum can adjust the signal transduction caused by Fas/FasL,PKC and Ca~(2+),consequently induced the cell apoptosis of human villi and deciduas in early pregnancy.By doing so,Gongqing granum can prevent and treat abnormal uterus bleeding after drug abortion.The effect of clinical curative and adjustion of apoptosis singnal transduction of Gongqing granum are obviously better than Qianzhi and onefold drug abortion.
方法:研究分现代中医文献研究和临床研究两大部分。现代中医文献研究中,以防治药流后出血的现代中医文献为研究对象,建立证治方药数据库,运用文献研究和统计学分析相结合的方法,从频数分析、因子分析、聚类分析角度对本病病因病机及证治规律进行统计分析。临床研究中,将180例患者随机分为宫清药流组、茜芷药流组及单纯药流组,并设人工流产组(简称人流组)患者60例,在观察临床疗效的同时,收集各组人早孕绒毛、蜕膜组织,透射电镜下观察绒毛及蜕膜组织细胞超微结构变化,并检测细胞凋亡率(AR)、凋亡信号转导相关指标凋亡因子Fas信使核糖核酸(FasmRNA)、Fas配体信使核糖核酸(FasLmRNA)、凋亡因子Fas、Fas配体(FasL)、蛋白激酶C(PKC)、细胞内钙离子浓度([Ca~(2+)]i)表达变化,分析指标间的相关性。
结果:现代中医文献研究显示,瘀、虚、热是药流后异常子宫出血的基本病因病机,活血化瘀、益气养血、清热是防治本病的基本原则,分析出了防治本病的高频药物及其配伍规律,为以活血化瘀、益气养血、清热法为组方原则的宫清颗粒防治本病提供了中医文献学依据。临床研究发现:宫清药流组孕囊排出时间较茜芷药流组及单纯药流组明显缩短,均有非常显著性差异(P＜0.01);宫清药流组子宫出血量明显减少,与茜芷药流组比较有显著性差异(P＜0.05),与单纯药流组比较有非常显著性差异(P＜0.01);宫清药流组子宫出血天数较单纯药流组明显缩短,有显著性差异(P＜0.05),与茜芷药流组比较无显著性差异(P＞0.05)。单纯药流组人早孕绒毛及蜕膜组织细胞超微结构观察发现细胞凋亡倾向,凋亡信号转导指标检测显示FasmRNA及FasLmRNA基因表达、Fas及FasL蛋白表达、[Ca~(2+)]i明显升高,PKC蛋白表达明显降低,与人流组比较有非常显著性差异(P＜0.01)。宫清颗粒的作用趋势与单纯药流药物相同,其作用效果较茜芷药流组与单纯药流组显著,超微结构观察发现宫清药流组绒毛及蜕膜组织细胞出现典型的凋亡形态学改变,凋亡信号转导指标检测显示,AR、FasmRNA基因及FasLmRNA基因表达、Fas蛋白及FasL蛋白表达、[Ca~(2+)]i较茜芷药流组、单纯药流组明显升高(P＜0.05,P＜0.01),PKC蛋白表达显著降低(P＜0.05,P＜0.01)。宫清药流组AR与FasmRNA基因、FasLmRNA基因、Fas蛋白、FasL蛋白表达及[Ca~(2+)]i呈正相关,与PKC蛋白表达呈负相关;FasmRNA基因表达与Fas蛋白表达呈正相关,FasLmRNA基因表达与FasL蛋白表达呈正相关,PKC蛋白表达与[Ca~(2+)]i呈负相关。
结论:药流药物通过影响Fas/FasL、PKC、Ca~(2+)介导的细胞凋亡信号转导途径,引起人早孕绒毛滋养细胞及蜕膜细胞凋亡,这可能是其抗早孕的机理之一。细胞凋亡不仅是药流的启动因素,同时凋亡障碍也是导致药流后异常子宫出血的原因之一。瘀、虚、热是药流后异常子宫出血的基本病因病机,以活血化瘀、益气养血、清热为组方原则的宫清颗粒从基因及蛋白水平调控Fas/FasL、PKC、Ca~(2+)介导的细胞凋亡信号转导途径,诱导药流人早孕绒毛滋养细胞及蜕膜细胞凋亡,促进绒毛与蜕膜组织的完全排出,进而达到防治药流后异常子宫出血的目的,其临床疗效及对细胞凋亡信号转导相关指标的调节作用明显优于茜芷药流组和单纯药流组。
Objective:To investigate the inducement mechanism of Gongqing granum concerning singnal transduction of human villi and decidua cell apoptosis,which is in the early pregnancy bleeding after drug abortion.In order to provide objective basis for preventing and treating the disease by Gongqing granum,furthermore,enrich the scientific connotation of the TCM theory that "there are more fragility and blood stasis after production".
Methods:In the modern TCM literature study,a database of recipes and herbs was founded with computer technology.Then analyzed the therapia rule from the point of frequency analysis,factor analysis and varable clustering analysis.In the clinical experimental investigation,the selected 240 patients were divided into 4 groups by random.They were group of Gongqing,group of Qianzhi,group of drug abortiona and group of induced abortion respectively.We observed the clinical curative effect of the 4 groups,at the same time,we collected the specimen of the 4 groups.Then we observed the ultrastructure of the specimen and detected the expression of apoptosis rate(AR) and correlative indexs of singnal transduction of cell apoptosis,such as FasmRNA,FasLmRNA, Fas,FasL,PKC and intracellular calcium concentration([Ca~(2+)])i,furthermore,we analyzed the relativity of the indexs.
Results:The TCM literature study showed that the main pathogen of bleeding after drug abortion were blood stasis,fragility and heat,which offered the philology evidence of Gongqing granula preventing and treating bleeding after drug abortion.The clinical experimental investigation showed that the clinical curative effect of Gongqing granum was obviously better than other groups(P＜0.01,P＜0.05).
The observation of ultrastructure indicated distinct change of apoptosis.Compared to the other 3 groups,the expression of AR,FasmRNA,FasLmRNA,Fas,FasL and([Ca~(2+)])i of Gongqing group were obviously higher than the other 3 groups(P＜0.01,P＜0.05),while the expression of PKC of Gongqing group was obviously lower than other 3 groups(P＜0.01, P＜0.05).
Results:Mifepristone can affect the singnal transduction of cell apoptosis caused by singnal transduction Fas/FasL,PKC and Ca~(2+).This may be one of the mechanisms of drug abortion.Blood stasis,fragility and heat are the main reasons of bleeding after drug abortion.Gongqing granum can adjust the signal transduction caused by Fas/FasL,PKC and Ca~(2+),consequently induced the cell apoptosis of human villi and deciduas in early pregnancy.By doing so,Gongqing granum can prevent and treat abnormal uterus bleeding after drug abortion.The effect of clinical curative and adjustion of apoptosis singnal transduction of Gongqing granum are obviously better than Qianzhi and onefold drug abortion.
引文
[1]经小平,翁梨驹,董白桦,等.诚年月泰用于药物流产的临床观察[J].中国计划生育学杂志,2001,66(2):104-106.
[2]Spitz IM,Bardin CW.Clinical pharmacology of RU 486 and antiprogestin and antiglu-cocorticoid [J].Contraception,1993;48:403.
[3]杨亚洲.米非司酮对人早期妊娠绒毛细胞增殖和凋亡的影响[J].医学科技,1997,1(1):3-6.
[4]孙敬霞.米非司酮药物流产时绒毛膜及蜕膜组织的超微结构改变[J].中国实用妇科与产科杂志.2001,17(5):293-294.
[5]Mirakian R,Nye K,Palazzo FF,et al.Methods for detecting apoptosis in thyroid diseases [J].J Immunol Methods,2002,265:161-175.
[6]Akcali KC,Khan SA,Moulton BC.Effect of decidualization on the expression of bax and bcl-2 in the rat uterine endometrium[J].Endocrinology.1998,137(10):3123-3131.
[7]Shi WL,Wang JD,Fu Y,etal.The effect of RU486 on progesterone receptor in villous and extravillous trophoblast[J].Hum Reprod,2001,10(5):953-958.
[8]刘文琼,刘瑞芬,等.宫清方防治药物流产后阴道出血及对绒毛超微结构变化的影响[J].福建中医药,2003,34(1):12-14.
[9]曹泽毅.中华妇产科学.第1版.北京:人民卫生出版社,1999.2588
[10]上海市卫生局.妇产科诊疗常规.第1版.上海:科学技术出版社,1999.300
[11]中华人民共和国卫生部.中药新药临床研究指导原则.第一辑.1993.231
[12]肖碧莲,高纪,等.月经血量的测定方法[J1.中华妇产科杂志,1980,15:159-160..
[13]Migheli A,Cavalla P,Marino S,etal.A study ofapoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks[J].Neuropathol Exp Neurol,1994,53(6):606.
[14]Negoescu A,Lorimier P,Labat-Moleur.In situ apoptotic cell la-beling by the TUNEL method:improvement and evaluation on cell preparations.[J].Histochem Cytochem,1996,44(9):959.
[15]Brakebusch C,Nophar Y,Kemper O,etal.Cytoplasmic truncation of the p55 tumour necrosis factor(TNF) receptor abolishes signalling,but not induced shedding of the receptor[J].EMBOJ,1992,11(3):943-950.
[16]Muzio M,Chinnaiyan AM,Kischkel FC,etal.FLICE,a novel FADD-homologous ICE /CED-3-like protease,is recruited to the CD95(Fas/APO-1)death-inducing signaling complex[J].Cell,1996,85(6):817-827.
[17]Boldin MP,Goncharov TM,Goltsev YV,etal.Involvement of MACH,a novel MORT 1/FADD-interacting protease,in Fas/APO-1 and TNF receptor-induced cell death [J].Cell,1996,85(6):803-815.
[18]Hsu H,Shu HB,Pan MG,et al.TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptorl signal transduction pathways[J].Cell,1996,84(2):299-308.
[19]Kondo T,Matsuda T,Kitano T,etal.Role of c-jun expression increased by heat shock -and ceramide-activated caspase-3 in HL-60 cell apoptosis.Possible involvement of ceramide in heat shock-induced apoptosis[J].JBiolChem,2000,275(11)7668-7676.
[20]杨栋.神经酰胺在细胞凋亡中的作用[J].国际病理科学与临床杂志,2006,26(2):166-168.
[21]谭晓华.神经酰胺:细胞凋亡信号转导的第二信使分子[J].国外医学分子生物学分册,1999,21(1):10-14.
[22]Zhu GH,Wong BC,Slosberg ED,etal.Over expression of pro-teinkinase C-betalisoenzyme suppresses indomethacin-in-duce dapopto sisingastri cepithelial cells[J].Gastroenterology,2000,118:507-514.
[23]朱光旭,王小光.JNK/SAPK信号传递途径与细胞应激反应[J].国外医学·分子生物学分册,2000,22(6):371-374.
[24]金伯泉.细胞和分子免疫学[M].北京:科学出版社,2001,第2版.608-622.
[25]成宇帆.CPP32在细胞凋亡中的作用[J].国外医学·生理、病理科学与临床分册,2001,21(1):7-9.
[26]Yakovlcva T,Pramanik A,Tercnius L,Ekstrom TJ,Bakalkin G p53 Latcncy-out of the blind alley[J].Trends Biochem Sci,2002,27(12):612-618.
[27]朱海青,线粒体在细胞凋亡中的作用.国外医学分子生物学分册,2002,22(1):27-29.
[28]Wallace DC.Mitochondrial diseases in man and mouse.Science,1999;283(5407):1482.
[29]Khare PD,Shao XiL,Kuroki M,etal.Specifically targeted killing of carcinoem-bryonic antigen(CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase.CanceRes,2001,61(1):3702375.
[30]冯丰.金属元素与细胞凋亡[J].国外医学.卫生学分册,2000,27(4):235-238.
[31]彭黎明,王曾礼.细胞凋亡的基础与临床[M].北京:人民卫生出版社,2000,第1版,40-44.
[32]许霖水.细胞抗凋亡信号转导[J].国外医学·临床生物化学与检验学分册,2001,22(3):113-114.
[33]Spitz IM,Bardin CW.Clinical pharmacology of RU 486 anantiprogestin and antiglucocorticoid[J].Contraception,1993;48:403.
[34]Moulton BC.Transforming growth factor stimulates endometial stromal apoptosis in witor.Endorcinology,2002,14:133-151.
[35]Anjum R,Khar A.Differential regulation of apoptosis in AK-5 tumor cells by the proto- oncogene Bcl-2:presence of Bcl-2 dependent and independent pathways.FEBS Lett 2001,499(1-2):166-170.
[36]杨亚洲,曹泽毅,韩字研.米非司酮对人早孕绒毛细胞增殖和凋亡的影响.中华妇产科杂志,1998;33(5):268.
[37]何丽霞,曲陆荣,陈桂兰.米非司酮对人早孕蜕膜组织细胞凋亡的影响.生殖与避孕,1999;19(4):216.
[38]朴英杰.溶酶体.细胞生物学进展,1993;3(1):64.
[39]Krammer PH.CD95(APO-1/Fas)-mediated apoptosis:live and let die.Adv Immunol,1999,71:163-210.
[40]Runic R,Lockwood CJ,Ma Y,et al.Expression of Fas ligand byhuman cytotro-phoblasts:implication in placentation and fetalsurvival[J].J Clin Endocrinol Metab,1996,81(8):3119-3122.
[41]张月莲.正常与药物流产绒毛蜕膜组织细胞调亡及相关基因的表达[J].中华妇产科杂志,2002,37(4):220-223.
[42]杨亚洲.米非司酮对人早期妊娠绒毛ICE、Fas表达的影响.华西医大学报,1998;29(2):216-219.
[43]赵艳忠.药物流产失败者蜕膜细胞Fas/FasL的表达.生殖医学杂志,2006;15(2):88-92.
[44]赖仁胜.米非司酮影响早孕滋养细胞的信号传导和凋亡的机制研究.中国实用妇科与产科杂志;2000,16(10):599-602.
[45]Kaipia A,Chun SY,Eisenhauer K,etal.Tumor necrosis factor-alpha and its second messenger,ceramide,stimulate apoptosis in cultured ovarian follicles[J].Endocrinology,1996,137(11)4864.
[46]刘薇.肿瘤坏死因子与生殖调节[J].国外医学计划生册,2000,19(4):198.
[47]刘薇.药物流产前后血清TNF2A的变化和细胞凋亡现象的观察.山东大学学报(医学版).2002;(40)2:154-156.
[48]Wang Z.Prevent from bleeding after medical abortion through prolonged application of mifepristone with misoprostol for terminating early pregnancy.Chin J Obstet Gynecol,2000,35(9):554-557.
[49]杜群,王汝俊,徐勤.活血化瘀中药对慢性萎缩性胃炎大鼠细胞增殖及凋亡的研究[J].2003,20(2):136-139.
[50]陈培丰.清热解毒法诱导肿瘤细胞凋亡的研究[J].浙江中医学院学报 2003,27(1):12-15.
[51]曹立幸,李泽民,等.益气养血、固肾安胎法治疗肾虚流产保胎作用机理研究[J].2004,19(2):53-54.
[52]陈惠新,许岸高,等.黄参方剂诱导胃癌癌前病变细胞凋亡和影Bcl-2蛋白表达的研究[J].陕西中医,2001,22(7):438-440.
[53]袁静,肖东.槲皮素抗肿瘤作用研究进展[J].国外医学·中医中药分册,1996,18(5):3.
[54]黄晓军.三氧化二砷诱导细胞凋亡的调节[J].中华血液学杂志,1999,20志(5): 258-260.
[55]蔡循,陈国强,等.三氧化二砷诱导血液肿瘤细胞凋亡的机制研究[J].中华医学杂志,1999,79(6):452-455.
[56]刘玉涛,周禾,等.枸杞多糖对小鼠胸腺细胞凋亡的调节[J].北京医科大学学报,1996,28(2):111-112.
[57]王洪萍、刘瑞芬,宫清颗粒在药物流产中作用机制探讨.中国新药与临床杂志,2007,26(1):52-55.
[58]Palmer RM,Ferrige AG,Moncada.Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor[J].Nature,1987,327(6122):524-526.
[59]Kim YM,DeVera ME,Watkins SC,etal.Nitric oxide protects cultured rat heaptocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shockprotein 70 expression[J].BoilChem,1997,272(2):1402-1411.
[60]Connelly L,Palacios-Callender M,Ameixa C,etal.BiphasiC regulation of NFKappaB activity underlies the pro-and anti-inflammatory actions of nitric oxide[J].Immunol,2001,166(6):3873-3881.
[61]彭黎明,王曾礼.细胞凋亡的基础与临床[M].北京:人民卫生出版社,2000,第1版,153.
[62]张月莲,陈贵安,等.正常与药物流产绒毛蜕膜组织细胞调亡及相关基因的表达[J].中华妇产科杂志,2002,37(4):220-223.
[63]杨雪峰,任芬若,等.米非司酮对早孕蜕膜及绒毛中雌孕激素受体的影响[J].中国实用妇科与产科杂志,2000,16(10):605-606.
[64]丁峰,傅国强,等.米非司酮对人早孕期蜕膜细胞凋亡及Fas/FasL的影响[J].解放军医学杂志 2002;27(4):362-363.
[65]Azzi Angelo,Oscoboinik Daniel,HenseyCarmel,etal.The protein kinase C family[J].FEBS,1992;208;547-587.
[66]Song HJ,Sneddon AA,Barker PA,et al.[JNutr Cancer,2004,49(1):100-108.
[67]Kennerly DA.Diacylglycerol metabolism in mast cells.Analysis of lipid metabolic pathways using molecular species analysis of intermediate.[J].Biol Chem,1987; 262(34): 16305.
[68] TettenbornCSetal. 12-O-tetradecanoylphorbol-13-acetate activates phospha- tidyle- thanol and phosphatidylglycerol synthesis by phospholipase D in cell lysates. BiochemBiophysResCommun,1988;155(1):249.
[69] EvansVG. Multiple pathways to apoptosis.CellBiolInter,1993;17:461.
[70] Kizaki L et al. J Biol Chem, 1990;265(5):5280.
[71] Karin M et al. Control of transcription factors by signal transduction pathways: the beginning of the end TIBS, 1992;17(10):418.
[72] ColeKA,KohnEC.Calcium-mediated signal transduction: Biology,biochemistry and-therapy.CancerMe tastasisRev, 1990,13 (40):33.
[73] Shen AC. Jennings RB. Kinetics of calcium accumulation in acute myocardial ischemic injury.Am J Pathol 1972:67:441-447.
[74] Kooichi S.Umeda MItakura A.Drug Then 1994:8365-370.
[75] Chen SJ.Bradley ME.Lee TC. Chemical hypoxia triggers apoptosis of cultured neonatal rat cardiac myocytes: modulation by calcium-regulated proteases and protein kinasesMol Cell Biocheml998;178(1-2):141-9.
[1]乌毓明.抗早孕药物米非司酮的临床应用[J].国外医学计划生育分册,1994;(1):2.
[2]廖爱华.米非司酮的作用机制及临床应用[J].实用妇产科杂志,1994;10(1):15.
[3]梁惠芳,等.米非司酮配伍米索前列腺醇终止早期妊娠140例观察[J].陕西医学杂志,1995;24(1):12.
[4]乌毓明.米非司酮终止早孕的临床进展[J].实用妇产科杂志,1994;10(1):6.
[5]吴熙瑞.米非司酮终止早孕的研究及作用机理[J].实用妇产科杂志,1994;10(1):3.
[6]乌毓明.减量Ru486配伍卡前列甲酯栓终止早孕的临床研究[J].中国计划生育学杂志,1992;(2):16.
[7]杜明昆.米非司酮并用前列甲酯栓抗早孕的临床观察[J].中国计划生育学杂志,1992;(2):17.
[8]武淑英.米非司酮合并前列腺素终止早孕的临床观察[J].中国医刊,1995;30(9):29.
[9]陈子文.药物流产613例临床观察[J].中国计划生育学杂志,1995;3(1):38.
[10]张帝开,等.米非司酮合并丙酸睾丸酮配伍米索前列醇抗早孕研究[J].实用妇产科杂志,1994;10(1):22.
[11]WHO.Pregnancy termination with mifepristas and geme prostamulticenter eomparison between repeated doses and a single of mifepristone.Fertilsteril.1991;56(1):32.
[12]杨明明,等.米非司酮抗早孕效果和可接受性研究[J].生殖与避孕,1992;12(5):13.
[13]胡家骆,等.抗旱孕药物引起的不全流产大出血2例[J].实用妇产科杂志,1994;10(1):44.
[14]左春梅,陈治水.加味生化汤治疗药物流产后出血46例临床观察[J].中医药学报,1999,27(3):37.
[15]陈虹,魏祝娣.中药安宫饮治疗药物流产后阴道出血的临床研究[J].广州中医药大学学报,1999,16(1):21-23.
[16]郭廷文.未产孕妇人工流产原因分析[J].实用妇产科杂志,1999,15(5):251.
[17]吴小多,黄元英,张丽蓉.中药消结安配合米非司酮终止早孕临床观察[J].天津中医,1999,16(6):20.
[18]吴艳萍.益气活血祛瘀法治疗药物流产后阴道出血76例临床观察[J].中医药研究,1999,15(2):25.
[19]李秀华.止血方治疗药物流产后出血的临床与实验研究[J].四川中医,2003,10(21):12-14.
[20]王亮.药流术配伍安坤冲剂对减少阴道出血的临床观察[J].浙江中医学院学报,1999,23(5):32-33.
[21]张秋实,吴殿杰.珍珠母注射液治疗药物流产后出血98例临床观察[J].内蒙古中医药,1998,17(3):6-7.
[22]刘瑞芬.三草止血汤治疗药物流产后出血60例[J].福建中医药,1998,(3):2.
[23]孙显生.缩宫逐瘀汤治疗米非司酮配伍米索前列醇终止早孕后出血疗效观察[J].江西中医药,1999,(3):32.
[24]曾婧.清宫止血颗粒缩减药物流产后阴道不规则出血的实验研究和临床观察[P].成都:成都中医药大学硕士学位论文,2001.7.
[25]孙敬霞,韩向阳.米非司酮药物流产时绒毛及蜕膜的形态学改变[J].中国实用妇科与产科杂志,2000,16(10):597-598
[26]孙敬霞,邹恩昌,韩燕燕,等.米非司酮药物流产时绒毛膜及蜕膜组织的超微结构改变[J].中国实用妇科与产科杂志,2001,17(5):293-294.
[27]梁元晶,诸定寿,路欣,等.药物流产后子宫刮出物中hPL和PSβ1G及血管 的相关抗原初探[J].解剖学杂志,2003,26(1):16-19.
[28]梁元晶,许晴,诸定寿,等.人流组织和药流后刮出组织中hCG、hPL和PSβ1G 免疫细胞化学检测[J].免疫学杂志,2001,17(1):78.
[29]赵艳忠,翁梨驹,诸定寿.层粘连蛋白及纤维粘连蛋白与药流后子宫出血关系的研究[J].首都医科大学学报,2001,22(1):17-20.
[30]张彤迪,吴瑞芳,卜鲜绿,等.米非司酮配伍米索前列醇终止早孕后出血原因与卵巢功能状态关系的研究[J].实用妇产科杂志,2002,18(6):346-347
[31]田力,孙慧君,王平.中医治疗药物流产后卵巢囊肿疗效观察[J].中国中医药信息杂志,2000,7(10):63.
[32]王振海,张彤艳,吴瑞芳,等.药物流产后子宫出血与早孕蜕膜和绒毛雌、孕激素受体的关系[J].中华妇产科杂志,2000,35(3):180-181.
[33]杨雪峰,任芬若,白桦,等.米非司酮对早孕蜕膜及绒毛中雌孕激素受体的影响[J].中国实用妇科与产科杂志,2000,16(10):605-606.
[34]朱丽华,黄丽丽,黄荷凤.米非司酮药物流产后子宫内膜雌激素和孕激素受体亚型观察[J].中华医学杂志,2003,83(10):819-822.
[35]辛晓玲,李丽宏.表皮生长因子与胰岛素对人离体绒毛组织分泌HCS及HCG 的影响[J].中国实用妇科与产科杂志,2002,18(7):414-416.
[36]南秀牌,王欣,吴明辉,等.血清表皮因水平与药物流产后阴道出血的相关关系[J].生殖与避孕,2003,23(6):357-360.
[37]刘铭山.从血浆t-PA/PAI活性水平探讨药物流产后出血的机制研究[J].医学理论与实践,2003,16(10):1132-1133.
[38]张婷婷,叶伟成,戴德英.祛膜汤对药物流产后大鼠子宫血浆中NO、NOS 的影响[J].上海中医药杂志,2000,34(3):48-49.
[39]刘薇,王育华,刘明,等.药物流产后流血时间延长原因探讨[J].山东医药,2002,42(7):1-3.
[40]张丽萍.药物流产后出血中医治疗近况[J].新中医,1997;29(8):41.
[41]文世容,马佳,刘平.生化汤加味治疗药物流产后出血疗效观察[J].北京中医,1997;16(4):25.
[42]李淑萍.活血化瘀软坚散结法治疗子宫内膜异位症的研究[J].辽宁中医杂志, 1996;23(4):172.
[43]杜文斌.复宫活血汤治疗产后恶露不绝32例疗效分析[J].光明中医,1996;11(2):22.
[44]李克勤.逐瘀清宫汤治疗米非司酮米索前列醇流产后出血100例[J].山西中医,1995;11(1):18.
[45]蒋惠贞.活血化瘀法对药流后HCG水平下降伴出血不止的疗效观察[J].新中医,1995:29(9):24.
[46]李凡星.蜕膜丸影响米非司酮合并卡孕栓终止早孕效果的初步临床观察[J].中国计划生育学杂志,1994;2(4～5):253.
[47]谢波.妇宁袋泡剂治疗300例药物流产出血的临床观察[J].新中医,1997;29(7):21.
[48]刘瑞芬,杨文炎,等.米非司酮配伍米所前列腺醇加用宫净汤抗早孕60例临床观察[J]山东中医药大学学报,1997,21(6):439.
[49]刘凤英.芪蒲坤舌汤治疗药物流产后恶露不绝31例[J].广西中医药,1994;17(4):15.
[50]陈长江.药物流产后中医治疗近况[J].中医研究,1997;10(5):33.
[51]冉秀芬.蛭赭汤治疗药物流产后蜕膜残留[J].中国计划生育学杂志,1995;3(3):170.
[52]赵霖恩.祛瘀益母汤治疗药物流产后流血时间过长96例[J].云南中医学院学报,1995;18(1):34.
[53]张琼芳.清宫止血饮治疗药物及人工流产后出血[J].中国医药学报,1995;10(6):29.
[54]赵荣胜.安宫冲剂减轻息隐药流后出血270例临床观察[J].北京中医药大学学报,1996;19(1):62.
[55]王学瑞.中医药治疗药物流产后出血的疗效观察[J].中医杂志,1993,(8):491.
[56]华山.珍珠母质提高药物流产率成功率的临床观察[J].浙江中医杂志,1998,35(9):432.
[57]法韫玉.紫草对药物流产临床效果的观察[J].生殖与避孕,1996,16(3):199.
[58]冷观群.益母片治疗药物流产后阴道出血98例疗效分析[J].中国中医急症, 2001,10(2):28.
[59]孙磊.云南白药减少药物流产后出血80例分析[J].中国计划生育学杂志,1999,7(4):173.
[60]方琼.应用中成藏药独一味片治疗药物流产后出血临床观察[J].中国计划生育学杂志,1999,7(10):461.
[61]商晶.麝香风湿膏贴脐提高药物流产成功率的临床观察[J].河南中医.2003,23(5):30.
[62]张永兴,陶枫.针灸防治药物流产出血的临床疗效观察[J].中国针灸.2001,21(4):195-197.
[63]林国翘,马美珍.米非司酮、丙酸睾丸酮配伍米索前列醇和生化汤抗早孕的临床研究[J]新医学,1995;26(2):74.
[64]姜慧波,陈桂枝,王锐.米非司酮配伍米索前列醇抗早孕420例临床观察[J],河北医药,1995;17(4):255.
[65]杨雪萍.米非司酮配伍米索前列醇终止33～62天早孕临床分析.[J]中国计划生育学杂志,1994;2(4):237.
[66]吴克明,龙旭,曾南,等.清宫止血颗粒对早孕大鼠子宫出血量与宫内膜形态的影响[J].成都中医药大学学报,2001,24(4):4-26.
[67]龙旭,吴克明,曾南.清宫止血颗粒缩减药物流产后出血的止血机理研究[J].中药新药与临床药理,2002,13(4):226-228.
[68]蒋惠贞,罗荣敬,徐志鑫.祛瘀止血汤对大鼠药物流产后离体子宫收缩的实验研究[J],河北中医,2004,26(1):74-75.
[69]张婷婷,戴德英.祛膜汤在治疗药流后出血中的作用及其机理研究[J].上海中医药杂志,2001,35(11):8-10.
[70]许梅芳,等.药物流产后子宫刮出物的组织学观察[J].生殖与避孕,1994;29(12):739.
[71]岳小玲.米非司酮与丙酸睾丸酮序贯配伍米索前列醇终止早孕临床效果观察[J].中国计划生育学杂志,1994:2(6):365.
[72]邹玉利.米非司酮配伍前列醇加肌注催产素抗早孕临床分析[J].中国计划生育学杂志,1994;2(增刊):56.
[1]Peyron R,Aubeny,Targosz V,etal.Early termination of pregnancy with mifepristone (RU486) andt heorallyactive prostagland in misoprostol.NEng lJ Med,1993,328(21):1509-1513.
[2]VonHertzen H,Honkanen H,Piaggio G,etal.WHO multinational study of three misoprostol regimens after mifepristone for early medicalabortion.BJOG,2003,110(9):808-818.
[3]经小平,翁梨驹,董白桦,等.诚年月泰用于药物流产的临床观察[J].中国计 划生育学杂志,2001,66(2):104-106.
[4]桑国卫,贺昌海,邵庆翔,等.米非司酮配伍前列腺素终止早孕17523例的大规模引入性研究.中国临床药学杂志,1999,15(5):323.
[5]Creinia MD,Schwal L,PymarHC,etal.Efficacy of mifepristone for early termination of pregnency:reportofar and omizedtrial.BJOG,2001,108(5):469-473.
[6]郑怀美.现代妇产科学[M],上海:上海医科大学出版社,1998,第1版.
[7]Hausknecht R.Mifepristone and misoprostol for early medicalabortion:18 months experienceintheUnitedStates.Contraception,2003,67:463-465.
[8]李玉萍,梁月华,严秋林.药物流产后阴道出血与子宫刮出物病理学观察分析 中国基层医药,2003,10:1125-1126.
[9]朱丽华,黄丽丽,黄荷凤.米非司酮药物流产后子宫内膜雌激素和孕激素受体亚型观察 中华医学杂志,2003,83:819-822.
[10]Moulton BC.Transforming growth factor stimulates endometial stromal apoptosis in witor.Endorcinology,2002,14:133-151.
[11]Anjum R,Khar A.Differential regulation of apoptosis in AK-5 tumor cells by the proto- oncogene Bcl-2:presence of Bcl-2 dependent and independent pathways.FEBS Lett 2001,499(1-2):166-170.
[12]Mirakian R,Nye K,Palazzo FF,et al.Methods for detecting apoptosis in medical abortion.J Immunol Methods,2002,265:161-175.
[13]Lne SA,Henderson TA,Kelly RW,etal.Leukocyte populations and steroid receptor expression in human first-trimester deciduasa regulation by antiprogestin and prostagl and in E analog[J].J Clin Endocrinol Metab,2005,90(7):4315-4321.
[14]Lomon Laurent J,Rozenberg P,Szekeres-Bartho J,etal.Changes in progesterone-induced -blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks[J].J Matern-Fetal Neonatal Med,2005,17(5):353-356.
[15]PettipherER,LabasiJM,Salter ED et al.BPharmacol,1996;117(7):1530-1534.
[16]祝红霞,米非司酮对母胎界面免疫耐受机制的影响,国外医学计划生育/生殖健康分册.2007,26(3):128-131.
[17]Alexander C M.Cell biology of extracellular matrix.New York:Hay ED,1991,12(2):54.
[18]许复华.纤维蛋白在生殖过程中的作用研究进展[J].生殖与避孕,1994,14(5):323.
[19]C Tessier,S.Deb,A.Prigent-Tessier,et,al.The evaluation of estrogen receptorin primary breast carcinoma by computer-assisted image analysis.Am J Clin Pathol.1988,90(3):233-239.
[20]李玉萍,梁月华,等.药物流产后阴道出血与子宫刮出物病理学观察分析[J].中国基层医 2003,1000:1125-1126.
[21]梁元晶,诸定寿,路欣,等.药物流产后子宫刮出物中hPL、PSβ1G及血管的相关抗原初探解剖学杂志,2003,26:16-20.
[22]朱聿君,黄丽丽,董岳.米非司酮抗早孕蜕膜碱性成纤维细胞生长因子变化的研究 生殖与避孕,2001,21:96-100
[23]南秀牌,王欣,吴明辉,等.血清表皮生长因子水平与药物流产后阴道出血的相关关系 生殖与避孕,2003,23:357-360.
[24]Shoupe D,,DR,Brenner PF,etal.Pregnancy termination widl a high andmidiu dosage regimen of Ru486.Contraception,1986,33:455.
[25]闰梨,张会真,王德智.米非司酮对早孕妇女血纤溶系统部分指标的影响(J).中国计划生育学杂志,1998,6(5):219.
[26]WHO.Pregnancytermination with mifepristone and gemeprost:amulticenter comparisio betweenrepeatedandasingledoseofmifepris tone.FertilSteril,1991,56(1):32.
[27]孟叙民,刘静芳,梁洪蒙,等.药物流产后加服米非司酮对缩短阴道出血时间的临床观察.实用妇产科杂志,1999,15(1):39-40.
[28]赵艳,金风珍,汪莉红.药物流产后加服米索前列醇减少阴道出血的临床观察.中国计划生育学杂志,2000,8(2):88-89.
[29]吴耀新.药物流产后加用雌激素缩短阴道出血时间的观察.华夏医学,2005,18(4):582-583.
[30]刘正平,张娟,胡晓萍,等.随机双盲口服复方炔诺酮片防治药物流产后阴 道出血的临床研究.中国计划生育学杂志,2000,8(9):398-399.
[31]王洪艳,朱立伟,王沛连.丙酸睾丸酮配合米非司酮米索前列醇终止早孕的研究.泰山医学院学报,2004,25(4):328-330.
[32]秦胜荣.药物流产后加注催产素对缩短阴道流血时间的临床研究.中国妇幼保健,2005,20(19):2497.
[33]朱小明,史锦云,钱晓蕾,等.甲氨蝶呤和丙酸睾丸酮辅助加强药物流产的临床观察.现代妇产科进展,2001,10(1):450-477.
[2]Spitz IM,Bardin CW.Clinical pharmacology of RU 486 and antiprogestin and antiglu-cocorticoid [J].Contraception,1993;48:403.
[3]杨亚洲.米非司酮对人早期妊娠绒毛细胞增殖和凋亡的影响[J].医学科技,1997,1(1):3-6.
[4]孙敬霞.米非司酮药物流产时绒毛膜及蜕膜组织的超微结构改变[J].中国实用妇科与产科杂志.2001,17(5):293-294.
[5]Mirakian R,Nye K,Palazzo FF,et al.Methods for detecting apoptosis in thyroid diseases [J].J Immunol Methods,2002,265:161-175.
[6]Akcali KC,Khan SA,Moulton BC.Effect of decidualization on the expression of bax and bcl-2 in the rat uterine endometrium[J].Endocrinology.1998,137(10):3123-3131.
[7]Shi WL,Wang JD,Fu Y,etal.The effect of RU486 on progesterone receptor in villous and extravillous trophoblast[J].Hum Reprod,2001,10(5):953-958.
[8]刘文琼,刘瑞芬,等.宫清方防治药物流产后阴道出血及对绒毛超微结构变化的影响[J].福建中医药,2003,34(1):12-14.
[9]曹泽毅.中华妇产科学.第1版.北京:人民卫生出版社,1999.2588
[10]上海市卫生局.妇产科诊疗常规.第1版.上海:科学技术出版社,1999.300
[11]中华人民共和国卫生部.中药新药临床研究指导原则.第一辑.1993.231
[12]肖碧莲,高纪,等.月经血量的测定方法[J1.中华妇产科杂志,1980,15:159-160..
[13]Migheli A,Cavalla P,Marino S,etal.A study ofapoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks[J].Neuropathol Exp Neurol,1994,53(6):606.
[14]Negoescu A,Lorimier P,Labat-Moleur.In situ apoptotic cell la-beling by the TUNEL method:improvement and evaluation on cell preparations.[J].Histochem Cytochem,1996,44(9):959.
[15]Brakebusch C,Nophar Y,Kemper O,etal.Cytoplasmic truncation of the p55 tumour necrosis factor(TNF) receptor abolishes signalling,but not induced shedding of the receptor[J].EMBOJ,1992,11(3):943-950.
[16]Muzio M,Chinnaiyan AM,Kischkel FC,etal.FLICE,a novel FADD-homologous ICE /CED-3-like protease,is recruited to the CD95(Fas/APO-1)death-inducing signaling complex[J].Cell,1996,85(6):817-827.
[17]Boldin MP,Goncharov TM,Goltsev YV,etal.Involvement of MACH,a novel MORT 1/FADD-interacting protease,in Fas/APO-1 and TNF receptor-induced cell death [J].Cell,1996,85(6):803-815.
[18]Hsu H,Shu HB,Pan MG,et al.TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptorl signal transduction pathways[J].Cell,1996,84(2):299-308.
[19]Kondo T,Matsuda T,Kitano T,etal.Role of c-jun expression increased by heat shock -and ceramide-activated caspase-3 in HL-60 cell apoptosis.Possible involvement of ceramide in heat shock-induced apoptosis[J].JBiolChem,2000,275(11)7668-7676.
[20]杨栋.神经酰胺在细胞凋亡中的作用[J].国际病理科学与临床杂志,2006,26(2):166-168.
[21]谭晓华.神经酰胺:细胞凋亡信号转导的第二信使分子[J].国外医学分子生物学分册,1999,21(1):10-14.
[22]Zhu GH,Wong BC,Slosberg ED,etal.Over expression of pro-teinkinase C-betalisoenzyme suppresses indomethacin-in-duce dapopto sisingastri cepithelial cells[J].Gastroenterology,2000,118:507-514.
[23]朱光旭,王小光.JNK/SAPK信号传递途径与细胞应激反应[J].国外医学·分子生物学分册,2000,22(6):371-374.
[24]金伯泉.细胞和分子免疫学[M].北京:科学出版社,2001,第2版.608-622.
[25]成宇帆.CPP32在细胞凋亡中的作用[J].国外医学·生理、病理科学与临床分册,2001,21(1):7-9.
[26]Yakovlcva T,Pramanik A,Tercnius L,Ekstrom TJ,Bakalkin G p53 Latcncy-out of the blind alley[J].Trends Biochem Sci,2002,27(12):612-618.
[27]朱海青,线粒体在细胞凋亡中的作用.国外医学分子生物学分册,2002,22(1):27-29.
[28]Wallace DC.Mitochondrial diseases in man and mouse.Science,1999;283(5407):1482.
[29]Khare PD,Shao XiL,Kuroki M,etal.Specifically targeted killing of carcinoem-bryonic antigen(CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase.CanceRes,2001,61(1):3702375.
[30]冯丰.金属元素与细胞凋亡[J].国外医学.卫生学分册,2000,27(4):235-238.
[31]彭黎明,王曾礼.细胞凋亡的基础与临床[M].北京:人民卫生出版社,2000,第1版,40-44.
[32]许霖水.细胞抗凋亡信号转导[J].国外医学·临床生物化学与检验学分册,2001,22(3):113-114.
[33]Spitz IM,Bardin CW.Clinical pharmacology of RU 486 anantiprogestin and antiglucocorticoid[J].Contraception,1993;48:403.
[34]Moulton BC.Transforming growth factor stimulates endometial stromal apoptosis in witor.Endorcinology,2002,14:133-151.
[35]Anjum R,Khar A.Differential regulation of apoptosis in AK-5 tumor cells by the proto- oncogene Bcl-2:presence of Bcl-2 dependent and independent pathways.FEBS Lett 2001,499(1-2):166-170.
[36]杨亚洲,曹泽毅,韩字研.米非司酮对人早孕绒毛细胞增殖和凋亡的影响.中华妇产科杂志,1998;33(5):268.
[37]何丽霞,曲陆荣,陈桂兰.米非司酮对人早孕蜕膜组织细胞凋亡的影响.生殖与避孕,1999;19(4):216.
[38]朴英杰.溶酶体.细胞生物学进展,1993;3(1):64.
[39]Krammer PH.CD95(APO-1/Fas)-mediated apoptosis:live and let die.Adv Immunol,1999,71:163-210.
[40]Runic R,Lockwood CJ,Ma Y,et al.Expression of Fas ligand byhuman cytotro-phoblasts:implication in placentation and fetalsurvival[J].J Clin Endocrinol Metab,1996,81(8):3119-3122.
[41]张月莲.正常与药物流产绒毛蜕膜组织细胞调亡及相关基因的表达[J].中华妇产科杂志,2002,37(4):220-223.
[42]杨亚洲.米非司酮对人早期妊娠绒毛ICE、Fas表达的影响.华西医大学报,1998;29(2):216-219.
[43]赵艳忠.药物流产失败者蜕膜细胞Fas/FasL的表达.生殖医学杂志,2006;15(2):88-92.
[44]赖仁胜.米非司酮影响早孕滋养细胞的信号传导和凋亡的机制研究.中国实用妇科与产科杂志;2000,16(10):599-602.
[45]Kaipia A,Chun SY,Eisenhauer K,etal.Tumor necrosis factor-alpha and its second messenger,ceramide,stimulate apoptosis in cultured ovarian follicles[J].Endocrinology,1996,137(11)4864.
[46]刘薇.肿瘤坏死因子与生殖调节[J].国外医学计划生册,2000,19(4):198.
[47]刘薇.药物流产前后血清TNF2A的变化和细胞凋亡现象的观察.山东大学学报(医学版).2002;(40)2:154-156.
[48]Wang Z.Prevent from bleeding after medical abortion through prolonged application of mifepristone with misoprostol for terminating early pregnancy.Chin J Obstet Gynecol,2000,35(9):554-557.
[49]杜群,王汝俊,徐勤.活血化瘀中药对慢性萎缩性胃炎大鼠细胞增殖及凋亡的研究[J].2003,20(2):136-139.
[50]陈培丰.清热解毒法诱导肿瘤细胞凋亡的研究[J].浙江中医学院学报 2003,27(1):12-15.
[51]曹立幸,李泽民,等.益气养血、固肾安胎法治疗肾虚流产保胎作用机理研究[J].2004,19(2):53-54.
[52]陈惠新,许岸高,等.黄参方剂诱导胃癌癌前病变细胞凋亡和影Bcl-2蛋白表达的研究[J].陕西中医,2001,22(7):438-440.
[53]袁静,肖东.槲皮素抗肿瘤作用研究进展[J].国外医学·中医中药分册,1996,18(5):3.
[54]黄晓军.三氧化二砷诱导细胞凋亡的调节[J].中华血液学杂志,1999,20志(5): 258-260.
[55]蔡循,陈国强,等.三氧化二砷诱导血液肿瘤细胞凋亡的机制研究[J].中华医学杂志,1999,79(6):452-455.
[56]刘玉涛,周禾,等.枸杞多糖对小鼠胸腺细胞凋亡的调节[J].北京医科大学学报,1996,28(2):111-112.
[57]王洪萍、刘瑞芬,宫清颗粒在药物流产中作用机制探讨.中国新药与临床杂志,2007,26(1):52-55.
[58]Palmer RM,Ferrige AG,Moncada.Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor[J].Nature,1987,327(6122):524-526.
[59]Kim YM,DeVera ME,Watkins SC,etal.Nitric oxide protects cultured rat heaptocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shockprotein 70 expression[J].BoilChem,1997,272(2):1402-1411.
[60]Connelly L,Palacios-Callender M,Ameixa C,etal.BiphasiC regulation of NFKappaB activity underlies the pro-and anti-inflammatory actions of nitric oxide[J].Immunol,2001,166(6):3873-3881.
[61]彭黎明,王曾礼.细胞凋亡的基础与临床[M].北京:人民卫生出版社,2000,第1版,153.
[62]张月莲,陈贵安,等.正常与药物流产绒毛蜕膜组织细胞调亡及相关基因的表达[J].中华妇产科杂志,2002,37(4):220-223.
[63]杨雪峰,任芬若,等.米非司酮对早孕蜕膜及绒毛中雌孕激素受体的影响[J].中国实用妇科与产科杂志,2000,16(10):605-606.
[64]丁峰,傅国强,等.米非司酮对人早孕期蜕膜细胞凋亡及Fas/FasL的影响[J].解放军医学杂志 2002;27(4):362-363.
[65]Azzi Angelo,Oscoboinik Daniel,HenseyCarmel,etal.The protein kinase C family[J].FEBS,1992;208;547-587.
[66]Song HJ,Sneddon AA,Barker PA,et al.[JNutr Cancer,2004,49(1):100-108.
[67]Kennerly DA.Diacylglycerol metabolism in mast cells.Analysis of lipid metabolic pathways using molecular species analysis of intermediate.[J].Biol Chem,1987; 262(34): 16305.
[68] TettenbornCSetal. 12-O-tetradecanoylphorbol-13-acetate activates phospha- tidyle- thanol and phosphatidylglycerol synthesis by phospholipase D in cell lysates. BiochemBiophysResCommun,1988;155(1):249.
[69] EvansVG. Multiple pathways to apoptosis.CellBiolInter,1993;17:461.
[70] Kizaki L et al. J Biol Chem, 1990;265(5):5280.
[71] Karin M et al. Control of transcription factors by signal transduction pathways: the beginning of the end TIBS, 1992;17(10):418.
[72] ColeKA,KohnEC.Calcium-mediated signal transduction: Biology,biochemistry and-therapy.CancerMe tastasisRev, 1990,13 (40):33.
[73] Shen AC. Jennings RB. Kinetics of calcium accumulation in acute myocardial ischemic injury.Am J Pathol 1972:67:441-447.
[74] Kooichi S.Umeda MItakura A.Drug Then 1994:8365-370.
[75] Chen SJ.Bradley ME.Lee TC. Chemical hypoxia triggers apoptosis of cultured neonatal rat cardiac myocytes: modulation by calcium-regulated proteases and protein kinasesMol Cell Biocheml998;178(1-2):141-9.
[1]乌毓明.抗早孕药物米非司酮的临床应用[J].国外医学计划生育分册,1994;(1):2.
[2]廖爱华.米非司酮的作用机制及临床应用[J].实用妇产科杂志,1994;10(1):15.
[3]梁惠芳,等.米非司酮配伍米索前列腺醇终止早期妊娠140例观察[J].陕西医学杂志,1995;24(1):12.
[4]乌毓明.米非司酮终止早孕的临床进展[J].实用妇产科杂志,1994;10(1):6.
[5]吴熙瑞.米非司酮终止早孕的研究及作用机理[J].实用妇产科杂志,1994;10(1):3.
[6]乌毓明.减量Ru486配伍卡前列甲酯栓终止早孕的临床研究[J].中国计划生育学杂志,1992;(2):16.
[7]杜明昆.米非司酮并用前列甲酯栓抗早孕的临床观察[J].中国计划生育学杂志,1992;(2):17.
[8]武淑英.米非司酮合并前列腺素终止早孕的临床观察[J].中国医刊,1995;30(9):29.
[9]陈子文.药物流产613例临床观察[J].中国计划生育学杂志,1995;3(1):38.
[10]张帝开,等.米非司酮合并丙酸睾丸酮配伍米索前列醇抗早孕研究[J].实用妇产科杂志,1994;10(1):22.
[11]WHO.Pregnancy termination with mifepristas and geme prostamulticenter eomparison between repeated doses and a single of mifepristone.Fertilsteril.1991;56(1):32.
[12]杨明明,等.米非司酮抗早孕效果和可接受性研究[J].生殖与避孕,1992;12(5):13.
[13]胡家骆,等.抗旱孕药物引起的不全流产大出血2例[J].实用妇产科杂志,1994;10(1):44.
[14]左春梅,陈治水.加味生化汤治疗药物流产后出血46例临床观察[J].中医药学报,1999,27(3):37.
[15]陈虹,魏祝娣.中药安宫饮治疗药物流产后阴道出血的临床研究[J].广州中医药大学学报,1999,16(1):21-23.
[16]郭廷文.未产孕妇人工流产原因分析[J].实用妇产科杂志,1999,15(5):251.
[17]吴小多,黄元英,张丽蓉.中药消结安配合米非司酮终止早孕临床观察[J].天津中医,1999,16(6):20.
[18]吴艳萍.益气活血祛瘀法治疗药物流产后阴道出血76例临床观察[J].中医药研究,1999,15(2):25.
[19]李秀华.止血方治疗药物流产后出血的临床与实验研究[J].四川中医,2003,10(21):12-14.
[20]王亮.药流术配伍安坤冲剂对减少阴道出血的临床观察[J].浙江中医学院学报,1999,23(5):32-33.
[21]张秋实,吴殿杰.珍珠母注射液治疗药物流产后出血98例临床观察[J].内蒙古中医药,1998,17(3):6-7.
[22]刘瑞芬.三草止血汤治疗药物流产后出血60例[J].福建中医药,1998,(3):2.
[23]孙显生.缩宫逐瘀汤治疗米非司酮配伍米索前列醇终止早孕后出血疗效观察[J].江西中医药,1999,(3):32.
[24]曾婧.清宫止血颗粒缩减药物流产后阴道不规则出血的实验研究和临床观察[P].成都:成都中医药大学硕士学位论文,2001.7.
[25]孙敬霞,韩向阳.米非司酮药物流产时绒毛及蜕膜的形态学改变[J].中国实用妇科与产科杂志,2000,16(10):597-598
[26]孙敬霞,邹恩昌,韩燕燕,等.米非司酮药物流产时绒毛膜及蜕膜组织的超微结构改变[J].中国实用妇科与产科杂志,2001,17(5):293-294.
[27]梁元晶,诸定寿,路欣,等.药物流产后子宫刮出物中hPL和PSβ1G及血管 的相关抗原初探[J].解剖学杂志,2003,26(1):16-19.
[28]梁元晶,许晴,诸定寿,等.人流组织和药流后刮出组织中hCG、hPL和PSβ1G 免疫细胞化学检测[J].免疫学杂志,2001,17(1):78.
[29]赵艳忠,翁梨驹,诸定寿.层粘连蛋白及纤维粘连蛋白与药流后子宫出血关系的研究[J].首都医科大学学报,2001,22(1):17-20.
[30]张彤迪,吴瑞芳,卜鲜绿,等.米非司酮配伍米索前列醇终止早孕后出血原因与卵巢功能状态关系的研究[J].实用妇产科杂志,2002,18(6):346-347
[31]田力,孙慧君,王平.中医治疗药物流产后卵巢囊肿疗效观察[J].中国中医药信息杂志,2000,7(10):63.
[32]王振海,张彤艳,吴瑞芳,等.药物流产后子宫出血与早孕蜕膜和绒毛雌、孕激素受体的关系[J].中华妇产科杂志,2000,35(3):180-181.
[33]杨雪峰,任芬若,白桦,等.米非司酮对早孕蜕膜及绒毛中雌孕激素受体的影响[J].中国实用妇科与产科杂志,2000,16(10):605-606.
[34]朱丽华,黄丽丽,黄荷凤.米非司酮药物流产后子宫内膜雌激素和孕激素受体亚型观察[J].中华医学杂志,2003,83(10):819-822.
[35]辛晓玲,李丽宏.表皮生长因子与胰岛素对人离体绒毛组织分泌HCS及HCG 的影响[J].中国实用妇科与产科杂志,2002,18(7):414-416.
[36]南秀牌,王欣,吴明辉,等.血清表皮因水平与药物流产后阴道出血的相关关系[J].生殖与避孕,2003,23(6):357-360.
[37]刘铭山.从血浆t-PA/PAI活性水平探讨药物流产后出血的机制研究[J].医学理论与实践,2003,16(10):1132-1133.
[38]张婷婷,叶伟成,戴德英.祛膜汤对药物流产后大鼠子宫血浆中NO、NOS 的影响[J].上海中医药杂志,2000,34(3):48-49.
[39]刘薇,王育华,刘明,等.药物流产后流血时间延长原因探讨[J].山东医药,2002,42(7):1-3.
[40]张丽萍.药物流产后出血中医治疗近况[J].新中医,1997;29(8):41.
[41]文世容,马佳,刘平.生化汤加味治疗药物流产后出血疗效观察[J].北京中医,1997;16(4):25.
[42]李淑萍.活血化瘀软坚散结法治疗子宫内膜异位症的研究[J].辽宁中医杂志, 1996;23(4):172.
[43]杜文斌.复宫活血汤治疗产后恶露不绝32例疗效分析[J].光明中医,1996;11(2):22.
[44]李克勤.逐瘀清宫汤治疗米非司酮米索前列醇流产后出血100例[J].山西中医,1995;11(1):18.
[45]蒋惠贞.活血化瘀法对药流后HCG水平下降伴出血不止的疗效观察[J].新中医,1995:29(9):24.
[46]李凡星.蜕膜丸影响米非司酮合并卡孕栓终止早孕效果的初步临床观察[J].中国计划生育学杂志,1994;2(4～5):253.
[47]谢波.妇宁袋泡剂治疗300例药物流产出血的临床观察[J].新中医,1997;29(7):21.
[48]刘瑞芬,杨文炎,等.米非司酮配伍米所前列腺醇加用宫净汤抗早孕60例临床观察[J]山东中医药大学学报,1997,21(6):439.
[49]刘凤英.芪蒲坤舌汤治疗药物流产后恶露不绝31例[J].广西中医药,1994;17(4):15.
[50]陈长江.药物流产后中医治疗近况[J].中医研究,1997;10(5):33.
[51]冉秀芬.蛭赭汤治疗药物流产后蜕膜残留[J].中国计划生育学杂志,1995;3(3):170.
[52]赵霖恩.祛瘀益母汤治疗药物流产后流血时间过长96例[J].云南中医学院学报,1995;18(1):34.
[53]张琼芳.清宫止血饮治疗药物及人工流产后出血[J].中国医药学报,1995;10(6):29.
[54]赵荣胜.安宫冲剂减轻息隐药流后出血270例临床观察[J].北京中医药大学学报,1996;19(1):62.
[55]王学瑞.中医药治疗药物流产后出血的疗效观察[J].中医杂志,1993,(8):491.
[56]华山.珍珠母质提高药物流产率成功率的临床观察[J].浙江中医杂志,1998,35(9):432.
[57]法韫玉.紫草对药物流产临床效果的观察[J].生殖与避孕,1996,16(3):199.
[58]冷观群.益母片治疗药物流产后阴道出血98例疗效分析[J].中国中医急症, 2001,10(2):28.
[59]孙磊.云南白药减少药物流产后出血80例分析[J].中国计划生育学杂志,1999,7(4):173.
[60]方琼.应用中成藏药独一味片治疗药物流产后出血临床观察[J].中国计划生育学杂志,1999,7(10):461.
[61]商晶.麝香风湿膏贴脐提高药物流产成功率的临床观察[J].河南中医.2003,23(5):30.
[62]张永兴,陶枫.针灸防治药物流产出血的临床疗效观察[J].中国针灸.2001,21(4):195-197.
[63]林国翘,马美珍.米非司酮、丙酸睾丸酮配伍米索前列醇和生化汤抗早孕的临床研究[J]新医学,1995;26(2):74.
[64]姜慧波,陈桂枝,王锐.米非司酮配伍米索前列醇抗早孕420例临床观察[J],河北医药,1995;17(4):255.
[65]杨雪萍.米非司酮配伍米索前列醇终止33～62天早孕临床分析.[J]中国计划生育学杂志,1994;2(4):237.
[66]吴克明,龙旭,曾南,等.清宫止血颗粒对早孕大鼠子宫出血量与宫内膜形态的影响[J].成都中医药大学学报,2001,24(4):4-26.
[67]龙旭,吴克明,曾南.清宫止血颗粒缩减药物流产后出血的止血机理研究[J].中药新药与临床药理,2002,13(4):226-228.
[68]蒋惠贞,罗荣敬,徐志鑫.祛瘀止血汤对大鼠药物流产后离体子宫收缩的实验研究[J],河北中医,2004,26(1):74-75.
[69]张婷婷,戴德英.祛膜汤在治疗药流后出血中的作用及其机理研究[J].上海中医药杂志,2001,35(11):8-10.
[70]许梅芳,等.药物流产后子宫刮出物的组织学观察[J].生殖与避孕,1994;29(12):739.
[71]岳小玲.米非司酮与丙酸睾丸酮序贯配伍米索前列醇终止早孕临床效果观察[J].中国计划生育学杂志,1994:2(6):365.
[72]邹玉利.米非司酮配伍前列醇加肌注催产素抗早孕临床分析[J].中国计划生育学杂志,1994;2(增刊):56.
[1]Peyron R,Aubeny,Targosz V,etal.Early termination of pregnancy with mifepristone (RU486) andt heorallyactive prostagland in misoprostol.NEng lJ Med,1993,328(21):1509-1513.
[2]VonHertzen H,Honkanen H,Piaggio G,etal.WHO multinational study of three misoprostol regimens after mifepristone for early medicalabortion.BJOG,2003,110(9):808-818.
[3]经小平,翁梨驹,董白桦,等.诚年月泰用于药物流产的临床观察[J].中国计 划生育学杂志,2001,66(2):104-106.
[4]桑国卫,贺昌海,邵庆翔,等.米非司酮配伍前列腺素终止早孕17523例的大规模引入性研究.中国临床药学杂志,1999,15(5):323.
[5]Creinia MD,Schwal L,PymarHC,etal.Efficacy of mifepristone for early termination of pregnency:reportofar and omizedtrial.BJOG,2001,108(5):469-473.
[6]郑怀美.现代妇产科学[M],上海:上海医科大学出版社,1998,第1版.
[7]Hausknecht R.Mifepristone and misoprostol for early medicalabortion:18 months experienceintheUnitedStates.Contraception,2003,67:463-465.
[8]李玉萍,梁月华,严秋林.药物流产后阴道出血与子宫刮出物病理学观察分析 中国基层医药,2003,10:1125-1126.
[9]朱丽华,黄丽丽,黄荷凤.米非司酮药物流产后子宫内膜雌激素和孕激素受体亚型观察 中华医学杂志,2003,83:819-822.
[10]Moulton BC.Transforming growth factor stimulates endometial stromal apoptosis in witor.Endorcinology,2002,14:133-151.
[11]Anjum R,Khar A.Differential regulation of apoptosis in AK-5 tumor cells by the proto- oncogene Bcl-2:presence of Bcl-2 dependent and independent pathways.FEBS Lett 2001,499(1-2):166-170.
[12]Mirakian R,Nye K,Palazzo FF,et al.Methods for detecting apoptosis in medical abortion.J Immunol Methods,2002,265:161-175.
[13]Lne SA,Henderson TA,Kelly RW,etal.Leukocyte populations and steroid receptor expression in human first-trimester deciduasa regulation by antiprogestin and prostagl and in E analog[J].J Clin Endocrinol Metab,2005,90(7):4315-4321.
[14]Lomon Laurent J,Rozenberg P,Szekeres-Bartho J,etal.Changes in progesterone-induced -blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks[J].J Matern-Fetal Neonatal Med,2005,17(5):353-356.
[15]PettipherER,LabasiJM,Salter ED et al.BPharmacol,1996;117(7):1530-1534.
[16]祝红霞,米非司酮对母胎界面免疫耐受机制的影响,国外医学计划生育/生殖健康分册.2007,26(3):128-131.
[17]Alexander C M.Cell biology of extracellular matrix.New York:Hay ED,1991,12(2):54.
[18]许复华.纤维蛋白在生殖过程中的作用研究进展[J].生殖与避孕,1994,14(5):323.
[19]C Tessier,S.Deb,A.Prigent-Tessier,et,al.The evaluation of estrogen receptorin primary breast carcinoma by computer-assisted image analysis.Am J Clin Pathol.1988,90(3):233-239.
[20]李玉萍,梁月华,等.药物流产后阴道出血与子宫刮出物病理学观察分析[J].中国基层医 2003,1000:1125-1126.
[21]梁元晶,诸定寿,路欣,等.药物流产后子宫刮出物中hPL、PSβ1G及血管的相关抗原初探解剖学杂志,2003,26:16-20.
[22]朱聿君,黄丽丽,董岳.米非司酮抗早孕蜕膜碱性成纤维细胞生长因子变化的研究 生殖与避孕,2001,21:96-100
[23]南秀牌,王欣,吴明辉,等.血清表皮生长因子水平与药物流产后阴道出血的相关关系 生殖与避孕,2003,23:357-360.
[24]Shoupe D,,DR,Brenner PF,etal.Pregnancy termination widl a high andmidiu dosage regimen of Ru486.Contraception,1986,33:455.
[25]闰梨,张会真,王德智.米非司酮对早孕妇女血纤溶系统部分指标的影响(J).中国计划生育学杂志,1998,6(5):219.
[26]WHO.Pregnancytermination with mifepristone and gemeprost:amulticenter comparisio betweenrepeatedandasingledoseofmifepris tone.FertilSteril,1991,56(1):32.
[27]孟叙民,刘静芳,梁洪蒙,等.药物流产后加服米非司酮对缩短阴道出血时间的临床观察.实用妇产科杂志,1999,15(1):39-40.
[28]赵艳,金风珍,汪莉红.药物流产后加服米索前列醇减少阴道出血的临床观察.中国计划生育学杂志,2000,8(2):88-89.
[29]吴耀新.药物流产后加用雌激素缩短阴道出血时间的观察.华夏医学,2005,18(4):582-583.
[30]刘正平,张娟,胡晓萍,等.随机双盲口服复方炔诺酮片防治药物流产后阴 道出血的临床研究.中国计划生育学杂志,2000,8(9):398-399.
[31]王洪艳,朱立伟,王沛连.丙酸睾丸酮配合米非司酮米索前列醇终止早孕的研究.泰山医学院学报,2004,25(4):328-330.
[32]秦胜荣.药物流产后加注催产素对缩短阴道流血时间的临床研究.中国妇幼保健,2005,20(19):2497.
[33]朱小明,史锦云,钱晓蕾,等.甲氨蝶呤和丙酸睾丸酮辅助加强药物流产的临床观察.现代妇产科进展,2001,10(1):450-477.